Perazzolo, S., Mandal, S., Prathipati, P. K., & Destache, C. J. (2020). Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments. Front Pharmacol.
Citação norma ChicagoPerazzolo, Simone, Subhra Mandal, Pavan K. Prathipati, and Christopher J. Destache. "Bictegravir Plus Tenofovir Alafenamide Nanoformulation As a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments." Front Pharmacol 2020.
Citação norma MLAPerazzolo, Simone, Subhra Mandal, Pavan K. Prathipati, and Christopher J. Destache. "Bictegravir Plus Tenofovir Alafenamide Nanoformulation As a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic Experiments." Front Pharmacol 2020.